[PERSON]
Arvind Nithrakashyap
Featured in 3 tracked stories · first seen
Situations
BioNTech corporate developments and oncology expansion
2 clusters · 3 sources · last updated
Latest: BioNTech expands oncology pipeline amid various corporate insider stock sales
BioNTech CEO Ugur Sahin executed multiple stock sales in early September, selling 149,500 shares at prices between approximately $96.31 and $103.52 per share. These transactions were conducted under a pre-arranged Rule 1